Metoprolol XL 50mg + Amlodipine 5mg + Metoprolol XL 25 mg + Amlodipine 2.5mg + Metoprolol XL 50mg + Metoprolol XL 25 mg + Amlodipine 5mg
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Primary Hypertension
Conditions
Primary Hypertension
Trial Timeline
Nov 1, 2008 → Aug 1, 2009
NCT ID
NCT00819104About Metoprolol XL 50mg + Amlodipine 5mg + Metoprolol XL 25 mg + Amlodipine 2.5mg + Metoprolol XL 50mg + Metoprolol XL 25 mg + Amlodipine 5mg
Metoprolol XL 50mg + Amlodipine 5mg + Metoprolol XL 25 mg + Amlodipine 2.5mg + Metoprolol XL 50mg + Metoprolol XL 25 mg + Amlodipine 5mg is a approved stage product being developed by AstraZeneca for Primary Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00819104. Target conditions include Primary Hypertension.
What happened to similar drugs?
20 of 20 similar drugs in Primary Hypertension were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00819104 | Approved | Completed |
Competing Products
20 competing products in Primary Hypertension